| Stock | Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
|
LLY Lilly(Eli) & Co
Challengers
|
2.02% |
23.83
|
4 |
49 |
4%
|
|
GSK Glaxosmithkline plc
|
5.43% |
21.77
|
3 |
37 |
-2%
|
|
HZNP Horizon Therapeutics Plc
|
- |
19.46
|
- |
- |
-
|
|
GWPH GW Pharmaceuticals
|
0.70% |
-78.26
|
- |
- |
-
|
|
PFE Pfizer Inc.
Contenders
|
3.91% |
24.88
|
4 |
49 |
6%
|
|
BAYRY BAYER AG
|
0.22% |
7.87
|
1 |
20 |
36%
|
|
NVS Novartis AG
|
3.40% |
81.10
|
1 |
24 |
1%
|
|
JNJ Johnson & Johnson
Champions
|
2.72% |
22.75
|
4 |
51 |
6%
|
|
MRK Merck & Co Inc
Challengers
|
3.00% |
19.61
|
4 |
51 |
6%
|
|
RHHBY ROCHE HOLDINGS AG
|
0.19% |
27.72
|
1 |
17 |
0%
|
|
GRFS Grifols SA
|
2.28% |
16.40
|
2 |
8 |
6%
|
|
BIIB Biogen Inc
|
0.00% |
7.91
|
- |
- |
-
|
|
SNY Sanofi
|
3.39% |
40.16
|
2 |
18 |
0%
|
|
AZN Astrazeneca plc
|
2.63% |
91.29
|
2 |
28 |
16%
|
|
GILD Gilead Sciences, Inc.
Challengers
|
4.34% |
60.67
|
4 |
6 |
11%
|
|
BMY Bristol-Myers Squibb Co.
Contenders
|
2.85% |
-224.30
|
4 |
49 |
8%
|
|
ABBV Abbvie Inc
Challengers
|
4.42% |
22.83
|
4 |
8 |
22%
|
|
AMGN AMGEN Inc.
Contenders
|
2.85% |
18.14
|
4 |
10 |
16%
|